Skip to content

Navigation

  • Map
  • Episodes
  • Articles
  • Advertise
  • About Us
  • Subscribe Free

Social

YouTube Spotify Apple Podcasts
  • Map
  • Episodes
  • Articles
  • Advertise
  • About Us
Subscribe Free
background-splash
Philip Hemme

Philip Hemme

Founder of Flot.bio | Author | Founder of Labiotech.eu (exit) | Bioengineer

Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50

Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50

Founded in 1979, Transgene has transformed itself into a leading personalized cancer vaccine player. Alessandro...
Philip Hemme
Philip Hemme
canceroncolytic virus
• Jan 12, 2026
Pascal Touchon 🇫🇷 | Cell Therapy, Jeito, Kymriah | E49

Pascal Touchon 🇫🇷 | Cell Therapy, Jeito, Kymriah | E49

Pascal Touchon unpacks why the next CAR-T innovations, including allogeneic and in vivo therapies, are...
Philip Hemme
Philip Hemme
CAR-Tcell therapy
• Jan 6, 2026
Abivax’s Record NASDAQ Stock Surge After Phase 3 Data

Abivax’s Record NASDAQ Stock Surge After Phase 3 Data

In biotech, Phase 3 data can change everything, or end everything. Few stories capture that...
Philip Hemme
Philip Hemme
biotech valuation jumpsdrug development execution
• Dec 21, 2025
Free Database of the Top 100 Public Biotechs in Europe

Free Database of the Top 100 Public Biotechs in Europe

The FlotBio Map is live at map.flot.bio 🙌 Here’s a bit of background FlotBio Map...
Philip Hemme
Philip Hemme
biotech companies
• Dec 21, 2025
Why AI in Biopharma Didn’t Live Up to the Hype

Why AI in Biopharma Didn’t Live Up to the Hype

AI has reshaped entire industries, from software development to entertainment, yet its impact in healthcare...
Philip Hemme
Philip Hemme
AIdrug development
• Dec 3, 2025
Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48

Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48

Why have early AI drug-discovery companies often overpromised but underdelivered? Biology is still complex and...
Philip Hemme
Philip Hemme
AIantibodies
• Dec 1, 2025
Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47

Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47

Valneva now has three commercialized vaccines and a Lyme disease candidate in Phase 3. Philip...
Philip Hemme
Philip Hemme
Lyme diseasevaccines
• Nov 24, 2025
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46

Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46

When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge...
Philip Hemme
Philip Hemme
Abivaxulcerative colitis
• Nov 18, 2025
Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45

Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45

As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into...
Philip Hemme
Philip Hemme
Nanobiotixnanoparticles
• Nov 10, 2025
Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]

Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]

As Philip tours Amsterdam, he visits the biotech tools startup LUMICKS. Founded in 2014, the...
Philip Hemme
Philip Hemme
CAR-TLUMICKS
• Oct 29, 2025

« 1 2 3 4 5 6 … 9 »

Never Miss a New Episode 💌

Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.

Newsletter preferences

Please select at least one option to subscribe.

By subscribing you agree to our privacy policy.

Watch & Subscribe

Flot.bio on Youtube Flot.bio on Spotify Flot.bio on Apple Podcasts
Flot.bio
  • Map
  • Episodes
  • Articles
  • About Us
  • Donate
  • Media Kit
  • Subscribe Free

Contact us via Katherine: hi@flot.bio

Follow Us:

Latest Episode:
Building a Liposome Biotech without VCs | Stefan Halbherr, InnoMedica | E64 [Sponsored]
Latest Article:
Top 35 Biotech Startups to Watch in Europe
Flot.bio © 2026
Made with ❤ in Europe 🇪🇺
  • Imprint
  • Privacy Policy